Skip to main content

Table 1 Patient baseline characteristics

From: Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication

Characteristic

Median (range)

Age (years)

66 (48–78)

TNM stage

 

T1c

70.5%

T2a

24.2%

T2b

5.4%

Gleason score

 

≤ 6

88.6%

7

11.4%

PSA (ng/ml)

5.56 (0.88 - 18.46)

< 10

89.8%

≥10

10.2%

IPSS (baseline)

3 (0–24)

≤ 3

57.6%

>3 and ≤12

38.2%

>12

4.2%

Prostate baseline volume (cc)

36.8 (14.4-67.7)

No. of needles

23 (16–32)

No. of seeds

58 (38–94)

Activity (mCi)

0.59 (0.4-0.65)

High (≥0.5mCi)

54.4%

Low (<0.5mCi)

45.6%

No of seeds/needle

2.6 (1.9-3.8)

  1. Abbreviations: TNM The American Joint Committee on Cancer staging, 7th edition, 2009, PSA prostate-specific antigen, IPSS International Prostate Symptom Score, cc cubic centimeters, mCi millicurie.